LAA Closure vs Warfarin for Stroke Prevention in Atrial Fibrillation
A left atrial appendage closure device provided a similar level of stroke prevention to that of warfarin in patients with atrial fibrillation.
A left atrial appendage closure device provided a similar level of stroke prevention to that of warfarin in patients with atrial fibrillation.
Percutaneous coronary intervention of the culprit lesion is associated with better 30-day outcomes than immediate multivessel PCI in patients with patients with multivessel CAD and acute MI.
Patients who received bioresorbable vascular scaffolds had higher rates of device thrombosis and target vessel MI compared with those who received everolimus-eluting stents.
Researchers analyzed 3-year outcomes in patients implanted with bioresorbable vascular scaffolds for the treatment of coronary lesions.
A substudy analyzed whether PCI outcomes using second generation drug eluting stents were comparable to CABG in patients with low or intermediated complexity left main coronary artery disease.